Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).
Arnedos M, Nerurkar A, Osin P, A'Hern R, Smith IE, Dowsett M
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of using CNB as opposed to EB for ER, PR, and HER2 status determination in early breast cancer specimens. The median time between collection of a CNB specimen and collection of an EB from the same patient was 27 days. Specimens were preserved in neutral buffered saline.
Summary of Findings
ER status was concordant between CNB and EB from the same tumor 98.2% of the time and showed discrepancy in 6 out of 336 paired specimens. In 5/6 of these cases, the positive ER score was borderline or modestly positive. PR status was concordant between CNB and EB only 85% of the time with almost equal division between CNB+/EB- and CNB-/EB+ cases. HER2 status was concordant between CNB and EB 98.8% of the time. In the four discrepant cases, 3 were CNB-/EB+ and 1 was CNB+/EB-. In the CNB positive specimen, FISH showed amplification between 2.0 and 3.0 indicating only low level amplification. The authors recommend against using CNB for PR status determination but deemed the use of CNB for ER and HER2 status determination acceptable.
Biospecimens
TissueBreastPreservation Types
Other PreservativeDiagnoses
NeoplasticCarcinomaPlatforms
ProteinImmunohistochemistryDNAFISHPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Method of tissue acquisition Core needle biopsyExcisional biopsyFISH Specific Targeted nucleic acid HER2Immunohistochemistry Specific Targeted peptide/protein ERHER2PR